Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol

Documenti analoghi

• Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting
  di: Andrea E. Scaramuzza, et al.
  Pubblicazione: (2025)
• Teplizumab: Not all that glitters is gold
  di: Andrea E. Scaramuzza, et al.
  Pubblicazione: (2025)
• Bridging dose of U‐100 glargine with first dose of insulin degludec improves glycaemia in the 48 h after transition in twice‐daily glargine users
  di: Arthi Thirumalai, et al.
  Pubblicazione: (2024)
• Glycaemic outcomes of a 4‐h insulin pump suspension for prolonged exercise in youth with type 1 diabetes
  di: Andrea E. Scaramuzza, et al.
  Pubblicazione: (2025)
• The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
  di: Yiming Mu
  Pubblicazione: (2024)